Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 50% ± 20% | |
peripheral blood | 19 studies | 57% ± 17% | |
intestine | 14 studies | 46% ± 24% | |
kidney | 8 studies | 47% ± 22% | |
liver | 6 studies | 35% ± 19% | |
uterus | 6 studies | 67% ± 24% | |
lymph node | 6 studies | 59% ± 24% | |
prostate | 5 studies | 46% ± 17% | |
pancreas | 4 studies | 37% ± 9% | |
bone marrow | 4 studies | 48% ± 24% | |
esophagus | 4 studies | 51% ± 17% | |
placenta | 4 studies | 26% ± 5% | |
skin | 4 studies | 66% ± 19% | |
breast | 4 studies | 64% ± 7% | |
ovary | 3 studies | 47% ± 22% | |
eye | 3 studies | 39% ± 17% | |
heart | 3 studies | 20% ± 4% | |
adipose | 3 studies | 43% ± 25% | |
adrenal gland | 3 studies | 57% ± 23% | |
stomach | 3 studies | 25% ± 1% | |
brain | 3 studies | 44% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 98% | 38186.06 | 1422 / 1445 | 99% | 623.56 | 182 / 183 |
lung | 100% | 84361.56 | 577 / 578 | 95% | 402.03 | 1102 / 1155 |
bladder | 100% | 40078.43 | 21 / 21 | 94% | 367.20 | 473 / 504 |
intestine | 96% | 36244.44 | 923 / 966 | 98% | 368.85 | 516 / 527 |
prostate | 96% | 26841.51 | 234 / 245 | 97% | 837.05 | 485 / 502 |
thymus | 92% | 42304.41 | 602 / 653 | 94% | 499.98 | 567 / 605 |
breast | 98% | 57994.24 | 448 / 459 | 83% | 275.44 | 925 / 1118 |
stomach | 76% | 33153.64 | 274 / 359 | 98% | 409.85 | 279 / 286 |
uterus | 83% | 25789.32 | 141 / 170 | 90% | 398.96 | 413 / 459 |
ovary | 78% | 34555.07 | 141 / 180 | 89% | 360.90 | 381 / 430 |
kidney | 79% | 19533.18 | 70 / 89 | 87% | 479.81 | 786 / 901 |
skin | 88% | 38961.03 | 1592 / 1809 | 53% | 99.22 | 250 / 472 |
liver | 65% | 16861.65 | 146 / 226 | 75% | 176.32 | 305 / 406 |
adrenal gland | 57% | 13405.69 | 146 / 258 | 65% | 251.03 | 150 / 230 |
pancreas | 20% | 2644.60 | 66 / 328 | 97% | 572.77 | 172 / 178 |
spleen | 100% | 21410.98 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 87.64 | 1 / 1 |
adipose | 99% | 83757.38 | 1190 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 46342.22 | 1318 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 386.54 | 42 / 45 |
peripheral blood | 93% | 35861.23 | 860 / 929 | 0% | 0 | 0 / 0 |
brain | 12% | 1837.22 | 330 / 2642 | 66% | 184.88 | 465 / 705 |
lymph node | 0% | 0 | 0 / 0 | 66% | 148.16 | 19 / 29 |
heart | 64% | 20607.95 | 549 / 861 | 0% | 0 | 0 / 0 |
muscle | 63% | 12312.07 | 504 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 4% | 3.86 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032680 | Biological process | regulation of tumor necrosis factor production |
GO_0043488 | Biological process | regulation of mRNA stability |
GO_0006402 | Biological process | mRNA catabolic process |
GO_0051028 | Biological process | mRNA transport |
GO_0000165 | Biological process | MAPK cascade |
GO_0032703 | Biological process | negative regulation of interleukin-2 production |
GO_0035278 | Biological process | miRNA-mediated gene silencing by inhibition of translation |
GO_0045647 | Biological process | negative regulation of erythrocyte differentiation |
GO_0071364 | Biological process | cellular response to epidermal growth factor stimulus |
GO_0060213 | Biological process | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening |
GO_1902037 | Biological process | negative regulation of hematopoietic stem cell differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0061158 | Biological process | 3'-UTR-mediated mRNA destabilization |
GO_0045616 | Biological process | regulation of keratinocyte differentiation |
GO_0042594 | Biological process | response to starvation |
GO_0031086 | Biological process | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay |
GO_0097011 | Biological process | cellular response to granulocyte macrophage colony-stimulating factor stimulus |
GO_0060218 | Biological process | hematopoietic stem cell differentiation |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_1900153 | Biological process | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO_1904582 | Biological process | positive regulation of intracellular mRNA localization |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0030099 | Biological process | myeloid cell differentiation |
GO_0045600 | Biological process | positive regulation of fat cell differentiation |
GO_0000289 | Biological process | nuclear-transcribed mRNA poly(A) tail shortening |
GO_0070935 | Biological process | 3'-UTR-mediated mRNA stabilization |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_1904246 | Biological process | negative regulation of polynucleotide adenylyltransferase activity |
GO_0000288 | Biological process | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO_0071385 | Biological process | cellular response to glucocorticoid stimulus |
GO_1902172 | Biological process | regulation of keratinocyte apoptotic process |
GO_0038066 | Biological process | p38MAPK cascade |
GO_1901835 | Biological process | positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA |
GO_0010837 | Biological process | regulation of keratinocyte proliferation |
GO_0009611 | Biological process | response to wounding |
GO_0044344 | Biological process | cellular response to fibroblast growth factor stimulus |
GO_0032897 | Biological process | negative regulation of viral transcription |
GO_2000637 | Biological process | positive regulation of miRNA-mediated gene silencing |
GO_0000178 | Cellular component | exosome (RNase complex) |
GO_0000932 | Cellular component | P-body |
GO_0030014 | Cellular component | CCR4-NOT complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005634 | Cellular component | nucleus |
GO_0070063 | Molecular function | RNA polymerase binding |
GO_0003677 | Molecular function | DNA binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0031072 | Molecular function | heat shock protein binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0071889 | Molecular function | 14-3-3 protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0035925 | Molecular function | mRNA 3'-UTR AU-rich region binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0019957 | Molecular function | C-C chemokine binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ZFP36 |
Protein name | mRNA decay activator protein ZFP36 (G0/G1 switch regulatory protein 24) (Growth factor-inducible nuclear protein NUP475) (Tristetraprolin) (Zinc finger protein 36) (Zfp-36) mRNA decay activator protein ZFP36 (Zinc finger protein 36) ZFP36 ring finger protein |
Synonyms | G0S24 NUP475 hCG_43352 TIS11A TTP RNF162A |
Description | FUNCTION: Zinc-finger RNA-binding protein that destabilizes several cytoplasmic AU-rich element (ARE)-containing mRNA transcripts by promoting their poly(A) tail removal or deadenylation, and hence provide a mechanism for attenuating protein synthesis . Acts as an 3'-untranslated region (UTR) ARE mRNA-binding adapter protein to communicate signaling events to the mRNA decay machinery . Recruits deadenylase CNOT7 (and probably the CCR4-NOT complex) via association with CNOT1, and hence promotes ARE-mediated mRNA deadenylation . Functions also by recruiting components of the cytoplasmic RNA decay machinery to the bound ARE-containing mRNAs . Self regulates by destabilizing its own mRNA . Binds to 3'-UTR ARE of numerous mRNAs and of its own mRNA . Plays a role in anti-inflammatory responses; suppresses tumor necrosis factor (TNF)-alpha production by stimulating ARE-mediated TNF-alpha mRNA decay and several other inflammatory ARE-containing mRNAs in interferon (IFN)- and/or lipopolysaccharide (LPS)-induced macrophages (By similarity). Also plays a role in the regulation of dendritic cell maturation at the post-transcriptional level, and hence operates as part of a negative feedback loop to limit the inflammatory response . Promotes ARE-mediated mRNA decay of hypoxia-inducible factor HIF1A mRNA during the response of endothelial cells to hypoxia . Positively regulates early adipogenesis of preadipocytes by promoting ARE-mediated mRNA decay of immediate early genes (IEGs) (By similarity). Negatively regulates hematopoietic/erythroid cell differentiation by promoting ARE-mediated mRNA decay of the transcription factor STAT5B mRNA . Plays a role in maintaining skeletal muscle satellite cell quiescence by promoting ARE-mediated mRNA decay of the myogenic determination factor MYOD1 mRNA (By similarity). Associates also with and regulates the expression of non-ARE-containing target mRNAs at the post-transcriptional level, such as MHC class I mRNAs . Participates in association with argonaute RISC catalytic components in the ARE-mediated mRNA decay mechanism; assists microRNA (miRNA) targeting ARE-containing mRNAs . May also play a role in the regulation of cytoplasmic mRNA decapping; enhances decapping of ARE-containing RNAs, in vitro . Involved in the delivery of target ARE-mRNAs to processing bodies (PBs) . In addition to its cytosolic mRNA-decay function, affects nuclear pre-mRNA processing (By similarity). Negatively regulates nuclear poly(A)-binding protein PABPN1-stimulated polyadenylation activity on ARE-containing pre-mRNA during LPS-stimulated macrophages (By similarity). Also involved in the regulation of stress granule (SG) and P-body (PB) formation and fusion (By similarity). Plays a role in the regulation of keratinocyte proliferation, differentiation and apoptosis . Plays a role as a tumor suppressor by inhibiting cell proliferation in breast cancer cells . .; FUNCTION: (Microbial infection) Negatively regulates HTLV-1 TAX-dependent transactivation of viral long terminal repeat (LTR) promoter. . FUNCTION: Zinc-finger RNA-binding protein that destabilizes several cytoplasmic AU-rich element (ARE)-containing mRNA transcripts by promoting their poly(A) tail removal or deadenylation, and hence provide a mechanism for attenuating protein synthesis. Acts as a 3'-untranslated region (UTR) ARE mRNA-binding adapter protein to communicate signaling events to the mRNA decay machinery. Functions by recruiting the CCR4-NOT deadenylase complex and probably other components of the cytoplasmic RNA decay machinery to the bound ARE-containing mRNAs, and hence promotes ARE-mediated mRNA deadenylation and decay processes. Binds to 3'-UTR ARE of numerous mRNAs. . |
Accessions | P26651 ENST00000597629.3 ENST00000594442.2 M0R252 M0QY76 ENST00000594045.2 |